20476 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Composition for preventing, alleviating or treating muscle diseases or improving muscular function
#902Cell surface anchoring antigen conjugates to treat cancer
#903Bioeffective krill oil compositions
#904Oxysterols and Hedgehog signaling
#905Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
#906Preparation and Uses of Obeticholic Acid
#907Cucurbitane tetracyclic triterpenoid compounds for application in treating pulmonary fibrosis
#908PROLIPOSOMAL TESTOSTERONE FORMULATIONS
#909Substituted steroids for the treatment of cancer
#910Methods of detecting progesterone receptor and of detecting an expression level
#911OXYSTEROLS FOR USE IN THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY VIRUSES
#912COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY
#913Pharmaceutical co-crystal and use thereof
#914Formulations for epidermal repair
#915Recovery and processing of human embryos formed in vivo
#916Cultivation of human noroviruses
#9177-dehydrocholesterol derivatives and methods using same
#918METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#919Methods for the separation and detection of an oxysterol
#920Compositions comprising triterpenoids
#921Methods of treating muscular dystrophy
#922BIOEFFECTIVE KRILL OIL COMPOSITIONS
#923Slow release oxysterols and methods of use
#924Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors
#925COMPOSITIONS COMPRISING TRITERPENOIDS
#926Methods of promoting hepatic regeneration
#927URSODEOXYCHOLIC ACID AND BRAIN DISORDERS
#928METHODS OF TREATING CANCER
#929COMPOUNDS AND FORMULATIONS FOR TREATING OPHTHALMIC DISEASES
#930Compositions for treating CMT and related disorders
#931Agent for treatment of PBC
#932COMBINED COMPOSITIONS FOR CONTROLLING BLOOD SUGAR LEVELS, HEPATOPROTECTION, AND FOR PREVENTION AND TREATMENT OF RELATED MEDICAL CONDITIONS
#933TREATMENT FOR PRIMARY BILIARY CHOLANGITIS
#934Methods and products to provide oral nutritional care to subjects with dementia
#935Rice bran sterol sugar-coated tablet
#936Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#937Synthetic bile acid compositions and methods
#938NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#939NON-MECHANICAL PROCESS FOR THE MICRONIZATION OF DIGOXIN
#940COMPOSITION COMPRISING CARNITINE, SODIUM CHOLATE, SODIUM ACETATE AND OPTIONALLY SILVER FOR USE IN THE TREATMENT OF PSORIASIS, VITILIGO AND ROSACEA
#941Oxysterols and methods of use thereof
#942PEDIATRIC FORMULATION
#943Pharmaceutical compositions to reduce complications of ocular steroid
#944INDUCTION OF LAMINA PROPRIA REGULATORY T CELLS
#945Bioeffective krill oil compositions
#946Chemical entities that kill senescent cells for use in treating age-related disease
#947EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#948INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS
#949Tunable endogenous protein degradation
#950Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection
#951Methods for reducing cellular proliferation and treating certain diseases
#952Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
#953COMPOSITIONS AND METHODS THAT MODULATE BACTERIA IN A COMPANION ANIMAL
#954Compositions and methods that modulate cholesterol in a companion animal
#955Compositions and methods that modulate phosphorus or enzymes in a companion animal
#956IBAT inhibitors for the treatment of liver diseases
#957COMPOSITIONS AND METHODS OF USING LAMELLAR BODIES FOR MODIFYING LINEAR BIOLOGICAL MACROMOLECULES
#958Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives
#959ORAL TESTOSTERONE UNDECANOATE THERAPY
#960Anticancer adjuvant containing panaxadiol ginsenocide compound
#961Methods and pharmaceutical compositions for treating peripheral demyelinating diseases
#962Artificial sebum film and method of producing same
#963PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION
#964Methods and compositions for treating and preventing viral infections
#965Treatment for hepatic fibrosis
#966FXR agonist compositions for combination therapy
#967Pharmaceutical composition for prevention, treatment or delay of Alzheimer's disease or dementia containing G protein-coupled receptor 19 agent as active ingredient
#968Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction
#969Compositions for improving cell viability and methods of use thereof
#970Composition for hypotonic lipolysis and manufacturing method thereof
#971PHARMACEUTICAL COMPOSITION AND METHODS
#972Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
#973Compositions and methods for treating dementia
#974Methods for protecting skin and/or promoting wound healing
#975Treatment of Pulmonary Disease
#976Compounds, compositions and methods useful for cholesterol mobilization
#977SKIN LIPIDOMIC ASSAY
#978CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#979PHARMACEUTICAL COMPOSITIONS
#980METHODS FOR MODULATING BONE DENSITY
#981Compounds that are analogs of squalamine, used as antibacterial agents
#982Targeting liver nuclear receptors as a treatment for wilson disease
#983IBAT inhibitors for the treatment of liver diseases
#984IBAT inhibitors for the treatment of liver diseases
#985Deuterated bile acids
#986Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereof
#987Dietary supplement
#988Disease severity index for assessment of chronic liver disease
#989IBAT inhibitors for the treatment of liver diseases
#990Methods and products for nucleic acid production and delivery
#991Recovery and processing of human embryos formed in vivo
#992Formulations of deoxycholic acid and salts thereof
#993Non-hormonal steroid modulators of NF-kB for treatment of disease
#994Methods and compositions for induction of immune response
#995Pharmaceutical compositions for combination therapy
#996Methods of treating and/or preventing affective disorders of the nervous system (depression) using aminosterols
#997Trimegestone (TMG) for treatment of preterm birth
#998Formulations of deoxycholic acid and salts thereof
#999Method for treatment of hyperglycemia and hyperlipidemia
#1000COMPOSITIONS CONTAINING A SPIRANTHES SINENSIS EXTRACT AND PHARMACEUTICAL APPLICATIONS THEREOF
#1001Hair composition
#1002BIOLOGICALLY-ACTIVE TOMATO COMPOSITION HAVING REDUCED AMOUNT OF LYCOPENE
#1003DISRUPTION OF THE INTERACTION BETWEEN AMYLOID BETA PEPTIDE AND DIETARY LIPIDS
#1004Medicinal composition of extract of seed of emblica officinalis and method of preparing the same
#1005Synthetic bile acid compositions and methods
#1006Food supplement for restoring male sex drive (libido)
#1007COMPOSITIONS AND METHODS FOR TREATING HIV-ASSOCIATED COGNITIVE DYSFUNCTION
#1008Methods of treating and preventing gastrointestinal motility disorders using aminosterols
#1009USES OF PORIA COCOS EPIDERMIS EXTRACT, PORICOIC ACID A, AND PORICOIC ACID B IN REGULATING BLOOD GLUCOSE LEVEL
#1010Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
#1011Methods of treating and/or preventing neurodevelopmental disorders (autism) using aminosterols
#1012Compound for treating clostridium difficile
#1013Methods for the purification of deoxycholic acid
#1014TREATMENT OF SUBMENTAL FAT
#1015MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR
#1016AGENT FOR PREVENTING OR IMPROVING SYMPTOMS CAUSED BY IMBALANCE OF SEX HORMONES
#1017Antileishmanial compositions and methods of use
#1018NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF
#1019ALTRENOGEST FORMULATION AND USES THEREOF FOR ESTRUS SYNCHRONISATION IN ANIMALS
#1020Modulators of ROR-gamma Receptors, Composition and Use Thereof
#1021Compositions and methods for improved muscle metabolism
#1022Methods and compositions for treating psoriasis
#1023Methods of treating cancer
#1024Treatment of submental fat
#1025Bile acid biomarkers for Niemann-Pick diseases, methods and uses therefor
#1026CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A OR STEROIDOGENESIS INHIBITORS
#1027USE OF DIHYDROCHOLESTEROL
#1028Chemical entities that kill senescent cells for use in treating age-related disease
#1029Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease
#1030Methods for the separation and detection of an oxysterol
#1031Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport
#1032ONAPRISTONE METABOLITE COMPOSITIONS AND METHODS
#1033Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
#1034Synthetic bile acid compositions and methods
#1035Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
#1036OXYGENATED CHOLESTEROL SULFATES FOR THERAPY OF DISORDERS CAUSED BY AT LEAST ONE OF ATTENUATED LEPTIN ACTIVITY AND A LIPID STORAGE DISORDER
#1037Oxysterols and methods of use thereof
#1038Bioeffective krill oil compositions
#1039METHODS AND FORMULATION FOR IMPROVING ORAL AVAILABILITY OF CPT-11 WHILE REDUCING CPT-11 INDUCED GASTROINTESTINAL TOXICITY IN CANCER THERAPY
#1040COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
#1041Method for preparing functional edible oil rich in phytosterol esters and diglycerides
#1042Compositions and methods for treating CNS disorders
#1043COMPOSITIONS AND METHODS TO TREAT AND/OR PREVENT VISION DISORDERS OF THE LENS OF THE EYE
#1044Method for preparing extract of genus including wild ginseng or ginseng, or cambial meristematic cells derived from genus or extract thereof containing rare ginsenosides in high quantity
#1045Compositions and methods useful for treating or preventing liver diseases or disorders, and promoting weight loss
#1046Methods for treating fungal infections
#1047Cholesterol lowering capsules
#1048METHOD FOR AVOIDING OR INHIBITION OF DYSKINESIA
#1049COMPOSITIONS FOR NAIL AND SKIN TREATMENT
#1050Use of dehydroeburicoic acid from in the treatment or prevention of diabetes and hyperlipidemia
#1051Combination therapies and methods of use thereof for treating cancer
#1052FARNESOID X RECEPTOR MODULATORS
#1053USES OF ERGOSTATRIEN-3beta-OL
#1054Sterol derivatives for treating neurosensory hearing loss, and corresponding composition
#1055Dietary supplement compositions for cardiovascular health
#1056Reconstituted high density lipoprotein formulation and production method thereof
#1057Composition comprising GPCR19 agonist as an active ingredient for preventing or treating allergic dermatitis
#1058Pharmaceutical composition comprising 7β-hydroxycholesterol intravenous administration
#1059TREATMENT OF INFLAMMATORY DEMYELINATING DISEASE WITH AGONISTS OF FARNESOID X RECEPTOR
#1060Compositions and methods for the repair of myelin
#1061FATTY ACID BILE ACID CONJUGATES FOR TREATMENT OF LIPODYSTROPHY
#1062TGR5 agonist complexes for treating diabetes and cancer
#1063Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections
#1064Compositions and Methods for Suppressing Endometrial Proliferation
#1065OXYSTEROLS AND HEDGEHOG SIGNALING
#1066PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE CANCER
#1067PHARMACEUTICAL COMPOSITION FOR TREATING LUNG CANCER
#1068PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL CANCER
#1069PHARMACEUTICAL COMPOSITION FOR TREATING BREAST CANCER
#1070Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
#1071Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
#1072Amorphous onapristone compositions and methods of making the same
#10734-pregenen-11β-17-21-triol-3,20-dione derivatives
#1074Treatment of fibrosis using FXR ligands
#1075EXTRACTING METHOD OF KUGUACIN, PHARMACEUTICAL COMPOSITION COMPRISING THE KUGUACIN AND USE THEREOF
#1076Medicinal composition of extract of seed of emblica officinalis and method of preparing the same
#1077Ship inhibition to induce activation of natural killer cells
#1078Infant nutrition for improving fatty acid composition of brain membranes
#1079METHOD OF IMPROVING THE MUSCLE QUALITY OF OBESE AND/OR SARCOPENIC MAMMALS USING PHYTOECDYSONES
#1080Synthetic bile acid compositions and methods
#1081Methods and compositions of bile acids and salts for reduction of fat
#1082Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration
#1083APPLICATION OF LARGE-DOSE GLYCERINUM IN FREEZE-THAWING TOLERABLE LIPID EMULSION
#1084TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF
#1085COMPOSITIONS AND METHODS FOR TREATING BONE AND JOINT INFECTIONS
#1086PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER
#1087Chemical induction of lactation in prepubescent non-human mammals
#1088TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPASE INHIBITORS
#1089Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
#1090METHOD AND EXTERNAL PREPARATION FOR LYMPHATIC SLIMMING
#1091Pharmaceutical composition based on a hepatoprotector and prebiotic, and method for administrating
#1092PHARMACEUTICAL COMPOSITION
#1093METHOD OF STABILIZING WEIGHT AFTER A WEIGHT-LOSS DIET USING PHYTOECDYSONES
#1094PEDIATRIC CHOLIC ACID FORMULATION
#1095Compositions and methods to treat vision disorders
#1096Serum cholesterol lowering edible product
#1097Proliposomal testosterone formulations
#1098Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth
#1099Implants having a drug load of an oxysterol and methods of use
#1100Derivatives of ergostatrien-3-β-ol from and antiglycemic, antihyperlipidemic and decreasing hepatic fat use thereof
#1101PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER
#1102Neuro-protective agents and uses thereof
#1103Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#1104Compositions of obeticholic acid and methods of use
#11057-dehydrocholesterol derivatives and methods using same
#1106Compositions for the treatment of cataracts
#1107Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#1108Non-Surgical Method of Treatment for Cataract
#1109Bile acid receptor agonism for treating addiction
#1110Cycloartenol-Containing Composition
#1111Uses of oxygenated cholesterol sulfates (OCS)
#1112WATER-DISPERSIBLE AMORPHOUS PARTICLES AND METHOD FOR PREPARING SAME
#1113Method for manufacturing aloe extract, and aloe extract
#1114Implants having a high drug load of an oxysterol and methods of use
#1115Slow release oxysterols and methods of use
#1116Materials, methods and devices for altering cell reactivity
#1117Composition containing fucosterol for skin whitening or moisturizing
#1118METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS
#1119METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES
#1120Medication of Suppressing Viability of Tumor Cells
#1121Topical formulations comprising a steroid
#1122Compounds, compositions and methods useful for cholesterol mobilization
#1123TOPICAL COMPOSITIONS AND METHODS OF USE
#1124Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods therefor
#1125PHARMACEUTICAL COMPOSITION BASED ON A HEPATOPROTECTOR AND A PREBIOTIC, AND PRODUCTION AND APPLICATION THEREOF
#1126Method of processing
#1127Phospholipid compositions and their preparation
#1128TOPICAL LIPOLYSIS COMPOSITIONS AND METHODS
#1129LIPOSOME COMPRISING AT LEAST ONE CHOLESTEROL DERIVATIVE
#1130Compositions and methods of use of phorbol esters in the treatment of neoplasms
#1131Methods and products for nucleic acid production and delivery
#1132Lipids and compositions for intracellular delivery of biologically active compounds
#1133Fusidic acid cream and method for the preparation thereof
#1134Glucocorticoid inhibitors for treatment of prostate cancer
#1135ROR GAMMA MODULATORS
#1136THERAPEUTIC COMPOUNDS THAT SUPPRESS PROTEIN ARGININE METHYLTRANSFERASE ACTIVITY FOR REDUCING TUMOR CELL PROLIFERATION
#1137Pharmaceutical compositions of carotenoid chylomicrons
#1138Thermal Fractionation Of Plant Material
#1139Methods and products to provide oral nutritional care to subjects with dementia
#1140Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof
#1141Polymyxin derivatives and their use in combination therapy together with different antibiotics
#1142Compositions and methods for improved muscle metabolism
#1143Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection
#1144Nutritional compositions with coated lipid globules
#1145Preparation and uses of obeticholic acid
#1146Treatment of Pulmonary Disease
#1147Methods and materials for reducing multiple risk factors associated with the metabolic syndrome
#1148OXYSTEROLS THAT ACTIVATE LIVER X RECEPTOR SIGNALING AND INHIBIT HEDGEHOG SIGNALING
#1149Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
#1150Peptides for enhancing transdermal delivery
#1151ANIMAL FEED INCLUDING CATIONIC CHOLESTEROL ADDITIVE AND RELATED METHODS
#1152IBAT inhibitors for the treatment of liver diseases
#1153IBAT inhibitors for the treatment of liver diseases
#1154Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors
#1155TREATMENT AND PREVENTION OF MASTITIS
#1156RETT SYNDROME AND TREATMENTS THEREFORE
#1157Compositions and methods for inhibiting norovirus infection
#1158COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS
#1159Biologically active food supplement
#1160Process for enhancing stem cell bioactivity using tauroursodeoxycholic acid
#1161Molecular Combinations for Cancer or Other Disease Treatment
#1162Polyhydroxylated bile acids for treatment of biliary disorders
#1163PHARMACEUTICAL COMPOSITION AND METHODS
#1164FORMULATIONS FOR EPIDERMAL REPAIR
#1165Channel modulators
#1166Preparation and uses of obeticholic acid
#1167USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID SPHINGOLIPID AND CHOLESTEROL
#1168TRIMEGESTONE (TMG) FOR TREATMENT OF PRETERM BIRTH
#1169ANTI-ACNE COMPOSITIONS COMPRISING BILE ACID-FATTY ACID CONJUGATES
#1170Combinations comprising MABA compounds and corticosteroids
#1171Deuterated bile acids
#1172SYSTEMS, DEVICES, AND METHODS INCLUDING PERSONAL VAPORIZING INHALERS HAVING CARTRIDGES CONFIGURED TO HOLD MULTIPLE UNIT DOSES
#1173Onapristone extended-release compositions and methods
#1174Bone-selective osteogenic oxysterol-bone targeting agents
#1175Laser assisted wound healing protocol and system
#1176PHARMACEUTICAL COMPOSITION ADJUVANT TO CHEMOTHERAPY DRUGS AND APPLICATIONS THEREOF
#1177Nitrated lipids and methods of making and using thereof
#1178COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)
#1179USE OF ERGOSTATRIEN-3ß-OL
#1180DRUG RELEASING AGENT BASED ON beta-SITOSTEROL AND A PREPARATION METHOD THEREOF
#1181Edible composition suitable for lowering serum cholesterol
#1182Synthetic bile acid compositions and methods
#1183SHIP INHIBITION TO COMBAT OBESITY
#1184Bile acid-basic amino acid conjugates and uses thereof
#1185Compositions for delivery of drug combinations
#1186Preparation and uses of obeticholic acid
#1187Cationic steroidal antimicrobial prodrug compositions and uses thereof
#1188Steroidal nitrones for the treatment and prevention of a cerebral stroke or ischaemia, alzheimer and parkinson disease and amyotrophic lateral sclerosis
#1189Methods and compositions for stimulating reepithelialisation during wound healing
#1190Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients
#1191MUCUS STRENGTHENING FORMULATIONS TO ALTER MUCUS BARRIER PROPERTIES
#1192Preparation and uses of obeticholic acid
#1193MEDICAMENT AND METHOD OF DIAGNOSIS
#1194Allosteric inhibitors of thymidylate synthase
#1195Non-hormonal steroid modulators of NF-κB for treatment of disease
#1196TGR5 modulators and methods of use thereof
#1197Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions
#1198PREVENTION AND TREATMENT OF KIDNEY DAMAGE
#1199Pharmaceutical compositions of carotenoid chylomicrons
#1200Nanoparticles, composed of sterol and saponin from for use in pharmaceutical compositions